USE OF CARNITINES AND RESVERATROL IN THE PRODUCTION OF A COMPOSITION FOR PREVENTING OR TREATING CEREBRAL DISEASES CAUSED BY AGING AND USE OF NEUROTOXIC AGENTS

摘要

A pharmaceutical product which comprises admixed or separately packaged (A) L-Carnitine or an alkanoyl L-canitine and (B) a trihydroxy- or tetrahydroxystilbene such as resveratrol is useful for the prevention and treatment of pathological neuronal or cerebral disorders.